Page 1 | Search Results | Blood | American Society of Hematology

1-19 of 19

Sort by

Sort Order Select

Journal Articles

Germline RBBP6 mutations in familial myeloproliferative neoplasms

Blood (2016) 127 (3): 362–365.

https://doi.org/10.1182/blood-2015-09-668673

Published: 2016

Includes: Supplemental data

Journal Articles

Whole-exome sequencing identifies novel MPL and JAK2 mutations in triple-negative myeloproliferative neoplasms

Blood (2016) 127 (3): 325–332.

https://doi.org/10.1182/blood-2015-07-661835

Published: 2016

Includes: Supplemental data

Journal Articles

Whole Exome Sequencing Identifies Novel MPL and JAK2 M utations in Triple Negative Myeloproliferative Neoplasms

Jelena D Milosevic Feenstra, PhD, Harini Nivarthi, PhD, Heinz Gisslinger, MD, Emilie Leroy, Elisa Rumi, MD, Ilyas Chachoua, Klaudia Bagienski, Blanka Kubesova, MSc, Daniela Pietra, PhD, Bettina Gisslinger, Roland Jäger, PhD, Doris Chen, PhD, Tiina Berg, B.Sc., Martin Schalling, MSc, Michael Schuster, PhD, Christoph Bock, PhD, Stefan N. Constantinescu, MD PhD, Mario Cazzola, MD, Robert Kralovics, PhD

Blood (2015) 126 (23): 606.

https://doi.org/10.1182/blood.V126.23.606.606

Published: 2015

Journal Articles

Calreticulin Mutation Status Predicts Improved Disease Outcome in Prefibrotic Primary Myelofibrosis but Not in WHO-Defined Essential Thrombocythemia

Heinz Gisslinger, MD, Juergen Thiele, MD PhD, Bettina Gisslinger, MSc, Tiina Berg, B.Sc., Martin Schalling, M.Sc., Ashot S Harutyunyan, MD, Jelena D. Milosevic, M.Sc., Klaudia Bagienski, M.Sc., Nicole C.C. Them, M.Sc., Veronika Buxhofer-Ausch, Guenther Nirnberger, Leonhard Muellauer, MD, Robert Kralovics, PhD

Blood (2014) 124 (21): 3167.

https://doi.org/10.1182/blood.V124.21.3167.3167

Published: 2014

Journal Articles

CALR exon 9 mutations are somatically acquired events in familial cases of essential thrombocythemia or primary myelofibrosis

Elisa Rumi, Ashot S. Harutyunyan, Daniela Pietra, Jelena D. Milosevic, Ilaria C. Casetti, Marta Bellini, Nicole C. C. Them, Chiara Cavalloni, Virginia V. Ferretti, Chiara Milanesi, Tiina Berg, Emanuela Sant’Antonio, Emanuela Boveri, Cristiana Pascutto, Cesare Astori, Robert Kralovics, Mario Cazzola

Blood (2014) 123 (15): 2416–2419.

https://doi.org/10.1182/blood-2014-01-550434

Published: 2014

Includes: Supplemental data

Journal Articles

JAK2 or CALR mutation status defines subtypes of essential thrombocythemia with substantially different clinical course and outcomes

Blood (2014) 123 (10): 1544–1551.

https://doi.org/10.1182/blood-2013-11-539098

Published: 2014

Includes: Supplemental data

Journal Articles

Frequent Mutations in the Calreticulin Gene CALR in Myeloproliferative Neoplasms

Blood (2013) 122 (21): LBA-1.

https://doi.org/10.1182/blood.V122.21.LBA-1.LBA-1

Published: 2013

Journal Articles

Analysis Of Molecular Responses and Chromosomal Aberrations In Patients With Polycythemia Vera Treated With Peg-Proline-Interferon Alpha-2b (AOP2014/P1101) In The Peginvera Study

Nicole C.C. Them, M.Sc., Heinz Gisslinger, MD, Veronika Buxhofer-Ausch, MD, Richard Greil, MD, Josef Thaler, MD, Ernst Schloegl, MD, Guenther A. Gastl, MD, Tiina Berg, Klaudia Bagienski, M.Sc., Oleh Zahriychuk, MD, Christoph Klade, PhD, Robert Kralovics, PhD

Blood (2013) 122 (21): 1589.

https://doi.org/10.1182/blood.V122.21.1589.1589

Published: 2013

Journal Articles

Whole Exome Sequencing Identifies Somatic Mutation Patterns Of Myeloid Cells In Patients With Myeloproliferative Neoplasms Treated With Allogeneic Bone Marrow Transplantation

Jelena D. Milosevic, Elisa Rumi, MD, Daniela Pietra, PhD, Klaudia Bagienski, M.Sc., Tiina Berg, Emanuela Sant'Antonio, MD, Anna Colombo, BsD, Francesco Ripamonti, MD, Mario Cazzola, MD, Robert Kralovics, PhD

Blood (2013) 122 (21): 4101.

https://doi.org/10.1182/blood.V122.21.4101.4101

Published: 2013

Journal Articles

Germline RBBP6 Mutations In Myeloproliferative Neoplasms

Blood (2013) 122 (21): 267.

https://doi.org/10.1182/blood.V122.21.267.267

Published: 2013

Journal Articles

Cytogenetic Aberration Profile of Chronic Myeloid Leukemia and Its Dynamic Changes During Imatinib Therapy,

Jelena D. Milosevic, Filip Razga, Dana Dvorakova, Tomas Jurcek, Tiina Berg, Ana Puda, Thorsten Klampfl, Ashot Harutyunyan, Bettina Gisslinger, Heinz Gisslinger, MD, Ester Orlandi, Paolo Bernasconi, Karel Indrak, Martina Divoka, Edgar Faber, Jiri Mayer, MD, Zdenek Racil, Robert Kralovics, PhD

Blood (2011) 118 (21): 3755.

https://doi.org/10.1182/blood.V118.21.3755.3755

Published: 2011

Journal Articles

Distinct Genetic Lesions Drive Leukemogenesis in Secondary Acute Myeloid Leukemia,

Blood (2011) 118 (21): 3559.

https://doi.org/10.1182/blood.V118.21.3559.3559

Published: 2011

Journal Articles

Genome integrity of myeloproliferative neoplasms in chronic phase and during disease progression

Thorsten Klampfl, Ashot Harutyunyan, Tiina Berg, Bettina Gisslinger, Martin Schalling, Klaudia Bagienski, Damla Olcaydu, Francesco Passamonti, Elisa Rumi, Daniela Pietra, Roland Jäger, Lisa Pieri, Paola Guglielmelli, Ilaria Iacobucci, Giovanni Martinelli, Mario Cazzola, Alessandro M. Vannucchi, Heinz Gisslinger, Robert Kralovics

Blood (2011) 118 (1): 167–176.

https://doi.org/10.1182/blood-2011-01-331678

Published: 2011

Includes: Supplemental data

Journal Articles

In Vivo Screening for Tumor Suppressors In Hematological Malignancies Using Barcode RNAi

Roland Jäger, Markus Muellner, Florian Grebien, Thorsten Klampfl, Ashot Harutyunyan, Damla Olcaydu, Tiina Berg, Sebastian Nijman, Robert Kralovics

Blood (2010) 116 (21): 998.

https://doi.org/10.1182/blood.V116.21.998.998

Published: 2010

Journal Articles

Characterization of Chromosome 20q Deletions In Myeloproliferative Neoplasms Using Microarray Karyotyping and Next-Generation Sequencing

Roland Jäger, Tiina Berg, Ashot Harutyunyan, Thorsten Klampfl, Francesco Passamonti, Elisa Rumi, Daniela Pietra, Bettina Gisslinger, Damla Olcaydu, Miroslav Penka, Heinz Gisslinger, Mario Cazzola, Robert Kralovics

Blood (2010) 116 (21): 4099.

https://doi.org/10.1182/blood.V116.21.4099.4099

Published: 2010

Journal Articles

Chromosomal Aberration Network In Myeloproliferative Neoplasms

Thorsten Klampfl, Ashot Harutyunyan, Tiina Berg, Bettina Gisslinger, Francesco Passamonti, MD, Elisa Rumi, Daniela Pietra, Damla Olcaydu, Roland Jäger, Mario Cazzola, MD, Heinz Gisslinger, Robert Kralovics

Blood (2010) 116 (21): 318.

https://doi.org/10.1182/blood.V116.21.318.318

Published: 2010

Journal Articles

Deletions of the Transcription Factor Ikaros in Myeloproliferative Neoplasms at Transformation to Acute Myeloid Leukemia.

Roland Jäger, Heinz Gisslinger, Tiina Berg, Francesco Passamonti, Mario Cazzola, Elisa Rumi, Daniela Pietra, Bettina Gisslinger, Thorsten Klampfl, Ashot Harutyunyan, Damla Olcaydu, Robert Kralovics

Blood (2009) 114 (22): 435.

https://doi.org/10.1182/blood.V114.22.435.435

Published: 2009

Journal Articles

Chromosomal Instability Causes Genetic and Clonal Heterogeneity in Myeloproliferative Neoplasms and Is Not Restricted to JAK2-V617F Positive Cells

Roland Jäger, Damla Olcaydu, Tiina Berg, Bettina Gisslinger, Heinz Gisslinger, Robert Kralovics

Blood (2008) 112 (11): 178.

https://doi.org/10.1182/blood.V112.11.178.178

Published: 2008

Journal Articles

Deletions of Chromosome 13q in Myeloproliferative Neoplasms: Mapping, Relation to the JAK2-V617F Mutation and Evaluation of Potential Tumor Suppressor Candidates

Damla Olcaydu, Tiina Berg, Bettina Gisslinger, Heinz Gisslinger, Robert Kralovics

Blood (2008) 112 (11): 3724.

https://doi.org/10.1182/blood.V112.11.3724.3724

Published: 2008

NARROW

Germline RBBP6 mutations in familial myeloproliferative neoplasms

Whole-exome sequencing identifies novel MPL and JAK2 mutations in triple-negative myeloproliferative neoplasms

Whole Exome Sequencing Identifies Novel MPL and JAK2 M utations in Triple Negative Myeloproliferative Neoplasms

Calreticulin Mutation Status Predicts Improved Disease Outcome in Prefibrotic Primary Myelofibrosis but Not in WHO-Defined Essential Thrombocythemia

CALR exon 9 mutations are somatically acquired events in familial cases of essential thrombocythemia or primary myelofibrosis

JAK2 or CALR mutation status defines subtypes of essential thrombocythemia with substantially different clinical course and outcomes

Frequent Mutations in the Calreticulin Gene CALR in Myeloproliferative Neoplasms

Analysis Of Molecular Responses and Chromosomal Aberrations In Patients With Polycythemia Vera Treated With Peg-Proline-Interferon Alpha-2b (AOP2014/P1101) In The Peginvera Study

Whole Exome Sequencing Identifies Somatic Mutation Patterns Of Myeloid Cells In Patients With Myeloproliferative Neoplasms Treated With Allogeneic Bone Marrow Transplantation

Germline RBBP6 Mutations In Myeloproliferative Neoplasms

Cytogenetic Aberration Profile of Chronic Myeloid Leukemia and Its Dynamic Changes During Imatinib Therapy,

Distinct Genetic Lesions Drive Leukemogenesis in Secondary Acute Myeloid Leukemia,

Genome integrity of myeloproliferative neoplasms in chronic phase and during disease progression

In Vivo Screening for Tumor Suppressors In Hematological Malignancies Using Barcode RNAi

Characterization of Chromosome 20q Deletions In Myeloproliferative Neoplasms Using Microarray Karyotyping and Next-Generation Sequencing

Chromosomal Aberration Network In Myeloproliferative Neoplasms

Deletions of the Transcription Factor Ikaros in Myeloproliferative Neoplasms at Transformation to Acute Myeloid Leukemia.

Chromosomal Instability Causes Genetic and Clonal Heterogeneity in Myeloproliferative Neoplasms and Is Not Restricted to JAK2-V617F Positive Cells

Deletions of Chromosome 13q in Myeloproliferative Neoplasms: Mapping, Relation to the JAK2-V617F Mutation and Evaluation of Potential Tumor Suppressor Candidates

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only